Living Cell Technologies Limited (LVCLF)

USD 0.01

(0.0%)

Revenue Summary of Living Cell Technologies Limited

  • Living Cell Technologies Limited's latest annual revenue in 2024 was 125.2 Thousand AUD , up 197.98% from previous year.
  • Living Cell Technologies Limited's latest quarterly revenue in 2024 FY was - AUD , down -100.0% from previous quarter.
  • Living Cell Technologies Limited reported a annual revenue of 42.01 Thousand AUD in annual revenue 2023, up 1133.95% from previous year.
  • Living Cell Technologies Limited reported a annual revenue of 3405.00 AUD in annual revenue 2022, down -98.73% from previous year.
  • Living Cell Technologies Limited reported a quarterly revenue of - AUD for 2024 Q2, down 0.0% from previous quarter.
  • Living Cell Technologies Limited reported a quarterly revenue of 62.6 Thousand AUD for 2024 Q3, down 0.0% from previous quarter.

Annual Revenue Chart of Living Cell Technologies Limited (2024 - 2004)

Historical Annual Revenue of Living Cell Technologies Limited (2024 - 2004)

Year Revenue Revenue Growth
2024 125.2 Thousand AUD 197.98%
2023 42.01 Thousand AUD 1133.95%
2022 3405.00 AUD -98.73%
2021 268.18 Thousand AUD 8365.4%
2020 3168.00 AUD -67.57%
2019 9769.00 AUD -91.95%
2018 121.4 Thousand AUD 5.31%
2017 115.27 Thousand AUD -4.01%
2016 120.09 Thousand AUD -80.38%
2015 611.95 Thousand AUD -91.72%
2014 7.39 Million AUD -2.45%
2013 7.58 Million AUD 104.42%
2012 3.7 Million AUD 2000.4%
2011 176.53 Thousand AUD -65.86%
2010 517.08 Thousand AUD 177.31%
2009 186.46 Thousand AUD 258.96%
2008 51.94 Thousand AUD 183.98%
2007 18.29 Thousand AUD 1299.54%
2006 1307.00 AUD -98.0%
2005 65.41 Thousand AUD -10.04%
2004 72.71 Thousand AUD 0.0%

Peer Revenue Comparison of Living Cell Technologies Limited

Name Revenue Revenue Difference
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.206%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -610.516%
SQZ Biotechnologies Company 21.47 Million USD 99.417%
Evofem Biosciences, Inc. 18.21 Million USD 99.313%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.898%
Mesoblast Limited 5.9 Million USD 97.879%
Propanc Biopharma, Inc. - USD -Infinity%
Genus plc 668.8 Million USD 99.981%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 69.476%
Marizyme, Inc. 645.81 Thousand USD 80.613%
ContraFect Corporation - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -63.104%
Intellipharmaceutics International Inc. 65.72 Thousand USD -90.482%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -216.818%
MultiCell Technologies, Inc. 49.32 USD -253752.393%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.748%
EV Biologics, Inc. 48.9 Thousand USD -156.033%
Q BioMed Inc. 284.35 Thousand USD 55.97%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.577%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.949%
Oncotelic Therapeutics, Inc. 70 Thousand USD -78.857%
Skye Bioscience, Inc. - USD -Infinity%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -26.472%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -65.337%
IMV Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 80.987%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.999%
Halberd Corporation 999.00 USD -12432.533%
Enzolytics Inc. 52.79 Thousand USD -137.139%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 90.855%
SYBLEU INC 11.69 Thousand USD -970.451%
Nuo Therapeutics, Inc. 608.52 Thousand USD 79.426%
argenx SE 1.22 Billion USD 99.99%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 93.52%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 79.721%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.985%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.914%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 77.551%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 87.451%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.741%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 99.25%
ONE Bio Corp. 52.29 Million USD 99.761%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 47.075%
Regen BioPharma, Inc. 236.56 Thousand USD 47.075%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 10.726%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 73.571%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 98.393%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -863.077%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -216.689%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 96.24%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 98.122%
IntelGenx Technologies Corp. 1.03 Million USD 87.95%
Gelesis Holdings, Inc. 25.76 Million USD 99.514%
CSL Limited 14.8 Billion USD 99.999%
Cellectis S.A. 755 Thousand USD 83.417%